Cellectis (CLLS) Cash & Current Investments (2016 - 2025)
Cellectis has reported Cash & Current Investments over the past 12 years, most recently at $61.7 million for Q4 2025.
- Quarterly results put Cash & Current Investments at $61.7 million for Q4 2025, down 76.3% from a year ago — trailing twelve months through Dec 2025 was $61.7 million (down 76.3% YoY), and the annual figure for FY2025 was $61.7 million, down 76.3%.
- Cash & Current Investments for Q4 2025 was $61.7 million at Cellectis, down from $260.3 million in the prior quarter.
- Over the last five years, Cash & Current Investments for CLLS hit a ceiling of $260.3 million in Q4 2024 and a floor of $1.1 million in Q2 2023.
- Median Cash & Current Investments over the past 5 years was $143.6 million (2021), compared with a mean of $133.7 million.
- Biggest five-year swings in Cash & Current Investments: soared 89.58% in 2023 and later plummeted 76.3% in 2025.
- Cellectis' Cash & Current Investments stood at $186.1 million in 2021, then crashed by 45.67% to $101.1 million in 2022, then soared by 89.58% to $191.7 million in 2023, then surged by 35.78% to $260.3 million in 2024, then plummeted by 76.3% to $61.7 million in 2025.
- The last three reported values for Cash & Current Investments were $61.7 million (Q4 2025), $260.3 million (Q4 2024), and $191.7 million (Q4 2023) per Business Quant data.